Risk of ovarian hyperstimulation syndrome in women with malignancies undergoing treatment with long-acting gonadotropin-releasing hormone agonist after controlled ovarian hyperstimulation for fertility preservation: a systematic review.

Ingold, Caroline; Navarro, Paula Andrea; de Oliveira, Renato; Barbosa, Caio Parente; Bedoschi, Giuliano

Ingold, Caroline; Navarro, Paula Andrea; de Oliveira, Renato; Barbosa, Caio Parente; Bedoschi, Giuliano.

Afiliación

Ingold C; Faculdade de Medicina do ABC, Santo Andre, Brazil.
Navarro PA; Department of Gynecology and Obstetrics, Reproductive Medicine Division, Ribeirao Preto Medical School, University of Sao Paulo, Sao Paulo, Brazil.
de Oliveira R; Faculdade de Medicina do ABC, Santo Andre, Brazil.
Barbosa CP; Faculdade de Medicina do ABC, Santo Andre, Brazil.
Bedoschi G; Department of Gynecology and Obstetrics, Reproductive Medicine Division, Ribeirao Preto Medical School, University of Sao Paulo, Avenida Bandeirantes, 3900, Ribeirao Preto, Sao Paulo 14040-900, Brazil.

Ther Adv Reprod Health ; 17: 26334941231196545, 2023.

Article en En | MEDLINE | ID: mdl-37674690

Palabras clave

fertility preservation; gonadotropin-releasing hormone; neoplasms; ovarian hyperstimulation syndrome; ovulation induction

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Ther Adv Reprod Health Año: 2023 Tipo del documento: Article País de afiliación: Brasil

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google